TABLE 3. A summary of double-blind, randomized, placebo-controlled clinical trials (RCTs) of aripiprazole augmentation.
MADRS: Montgomery-Åsberg Depression Rating Scale, ARP: aripiprazole, PBO: placebo, ap<0.05, ARP vs PBO, otherwise not significant, bIdentical RCT and analyzed differently on primary objective.